Cancer Biopsies Market Share

Statistics for the 2023 & 2024 Cancer Biopsies market share, created by Mordor Intelligence™ Industry Reports. Cancer Biopsies share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Oncology Diagnostics Research Cancer Biopsy Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Cancer Biopsies Industry

The cancer biopsies market is moderately competitive. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of cancer diseases, many regional players are expected to be a part of the cancer biopsies market over the forecast period. Some of the major players in the market are QIAGEN NV, Illumina Inc., Becton, Dickinson and Company, Myriad Genetics, and Thermo Fisher Scientific.

Cancer Biopsies Market Leaders

  1. Illumina, Inc.

  2. Becton, Dickinson and Company

  3. Myriad Genetics

  4. Thermo Fisher Scientific

  5. QIAGEN

*Disclaimer: Major Players sorted in no particular order

Cancer Biopsies Market.png

Cancer Biopsy Market Report Snapshots

Cancer Biopsy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)